Form 4 for MDGL MADRIGAL PHARMACEUTICALS, INC.
Accepted 2025-12-04 00:00:00 ET · period of report 2025-12-03 · accession 0001628280-25-055430 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-04 | 2025-12-03 | MDGL | Sibold William John | Pres, CEO, Dir | M - OptEx | — | +50.0K | 152.5K | +49% | — |
| D | 2025-12-04 | 2025-12-04 | MDGL | Sibold William John | Pres, CEO, Dir | S - Sale+OE | $575.34 | -2,400 | 150.1K | -2% | -$1.38M |
| D | 2025-12-04 | 2025-12-03 | MDGL | Sibold William John | Pres, CEO, Dir | M - OptEx | — | -50.0K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-03 | M | A | 50,000 | — | 152,474 | D | — | — | (F1) On December 3, 2025, the Reporting Person earned 50,000 shares of common stock following the achievement of the performance and service conditions of the Performance Restricted Stock Units described in Footnote 3. Pursuant to the terms of the award, certain of these shares were sold to cover certain tax withholding obligations as described in Footnote 2 below. The Issuer is irrevocably obligated to issue the remaining shares to the Reporting Person on September 8, 2028, the fifth anniversary of the commencement of his employment with the Issuer. |
| 2 | Common | Common Stock | 2025-12-04 | S | D | 2,400 | $575.34 | 150,074 | D | — | — | |
| 3 | Derivative | Performance Restricted Stock Units | 2025-12-03 | M | D | 50,000 | — | 0 | D | — · — to — | 50,000 Common Stock | (F3) On September 11, 2023, the Reporting Person was granted a one-time sign-on award of Performance Restricted Stock Units with a target award of 50,000 shares of common stock that can be earned upon the achievement of significant sustained stock price appreciation hurdles over a five-year period. The Reporting Person can earn up to 300% of the target award. Following the achievement of the first hurdle in February 2025 and the second hurdle reported on this line, the Reporting Person is eligible to earn an additional 50,000 shares upon the achievement of the final performance hurdle. See the Issuer's Schedule 14A filed with the Securities and Exchange Commission on April 29, 2024 for additional information about the Performance Restricted Stock Units. |